Search | ULY STAR

added article Other

2024-11-07 06:52:23 -

Combination of AMT-253 and Bevacizumab Enhances Tumor Suppression in Melanoma

The advent of BRAF inhibitors and immune checkpoint inhibitors (ICIs) has significantly improved the prognosis of melanoma patients. However, melanoma subtypes such as limbal, mucosal, and uveal melanomas are less responsive to these therapies than cutaneous melanomas, and new therapeutic agents are urgently needed for treatment-resistant patients. Antibody-drug conjugates (ADCs) achieve...

0 Comments 0 Shares 392 Views 0 Reviews